Publication | Open Access
Erenumab in chronic migraine with medication overuse
212
Citations
21
References
2019
Year
This study provides Class II evidence that erenumab reduces monthly migraine days at 3 months in patients with chronic migraine and medication overuse.
| Year | Citations | |
|---|---|---|
Page 1
Page 1